Stocks Health care TWST
NASDAQ · Health careTwist Bioscience Corp (TWST)
Twist Bioscience Corp brought in $431.8M of revenue over the twelve months to June 30, 2026, up 19.2% from a year earlier. It posted a net loss of $136.7M. In fiscal 2025 capital spending exceeded operating cash flow by $75.6M. At June 30, 2026 it held $117.4M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 3, 2026.
What Twist Bioscience Corp does
Twist Bioscience Corp is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker TWST.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $376.6M | -$77.7M | -$1.30 | -$75.6M |
| 2024 | $313M | -$208.7M | -$3.60 | -$69.2M |
| 2023 | $245.1M | -$204.6M | -$3.60 | -$170.3M |
| 2022 | $203.6M | -$217.9M | -$4.04 | -$226.2M |
| 2021 | $132.3M | -$152.1M | -$3.15 | -$139.3M |
| 2020 | $90.1M | -$139.9M | -$3.57 | -$152.1M |
Latest SEC filings
What Twist Bioscience Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 8, 2026Passive stake changed SCHEDULE 13G/A
- September 8, 2026Passive stake changed SCHEDULE 13G/A
- August 19, 2026Other event 8-K
- August 19, 2026
- August 19, 2026
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 14, 2026Passive stake (5% or more) SCHEDULE 13G
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 13, 2026Passive stake changed SCHEDULE 13G/A
- August 11, 2026Passive stake changed SCHEDULE 13G/A
Questions about TWST
What does Twist Bioscience Corp do?
Twist Bioscience Corp is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker TWST.
Is Twist Bioscience Corp profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $136.7M on revenue of $431.8M.
How much revenue does Twist Bioscience Corp make?
Over the twelve months to June 30, 2026 Twist Bioscience Corp reported revenue of $431.8M. That is 19.2% more than a year earlier.
When did Twist Bioscience Corp last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 3, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 25, 2026.
Similar companies
Follow TWST
Get an email when Twist Bioscience Corp files with the SEC: results, executive changes, material agreements and annual reports.
Follow TWST: get an email when it filesWhere the numbers come from
Financial figures are the values Twist Bioscience Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.